ViralHSVHZV

Risk group

Rare causes of lung disease. SCT recipients at greatest risk esp. MUDs and intensively treated lymphoid malignancy.

Treatment

High dose IV acyclovir 5-10mg/kg tds IV for minimum 10d. 557

Viral—RSV Risk group

Post-SCT recipients esp. MUDs. Treatment

Consider ribovarin therapy. TB and atypical mycobacteria Risk group

Prolonged T-cell immunosuppression e.g. chronic steroid or cyclosporin therapy, chronic GvHD, previous history and/or treatment for TB, HIV related disease.

Treatment

Often difficult to diagnose—empirical treatment required with standard triple therapy.

0 0

Post a comment